canSERV: Providing cutting edge cancer research services across Europe


canSERVs mission is to make cutting-edge and customised research services available to the cancer research community EU wide, enable innovative R&D projects and foster precision medicine for patients benefit across Europe. By connecting, coordinating, and aligning existing oncology and complimentary research infrastructures (RIs) and providing services in a synergistic way transnationally, canSERV will capitalise on the critical mass of experts and cutting-edge services offered by canSERVs RIs and their extended network. canSERV brings together world-class European life science RIs (BBMRI, EURO BIOIMAGING, ELIXIR, EU-IBISBA, EuroPDX, EU-OPENSCREEN, INSTRUCT, EATRIS, INFRAFRONTIER, EMBRC, ECRIN, EATRIS, MIRRI, ARIE, CCE, EORTC and IARC) that collectively not only covers all aspects along the development pipeline for oncology, but is also capable of interconnecting these technologies providing users a guidance for navigating them through the entire translational value chain. The patient organization ECPC will bring the patient’s perspective, while the two SMEs, ARTTIC and ttopstart, will provide valuable input regarding stakeholder engagement, and project management activities.

A common access management system (CAMS) will be developed based on mature solutions from INSTRUCT and BBMRI. The CAMS will provide a method for selection of services, construction and submission of research proposals, multi-step review of research proposals, and tracking of the access process from approval through delivery to conclusion. Through a united user-intuitive transnational access where a united catalogue of oncology services will be offered, our users will have access to a comprehensive service portfolio. As our ambition is to scale up canSERV to a pan-European collaboration of RIs for accelerating the development and implementation of solutions for the cancer patient community, the sustainability of this network beyond the end of the project will also be addressed.

Objetivos y Resultados

The main goal of the project is to establish an open and sustainable collaborative network of RIs in oncology which will offer world-class services valuable for all major stakeholders (e.g., excellent researchers, universities, institutes, high-profile SMEs, and European research consortia). Main objectives are:

● To offer at least 200 different unique Personalized Oncology (PO) relevant and valuable cutting-edge services for life science research in Europe over the next 3 years;
● To establish a single, unified transnational access and training for all services;
● To ensure data generated through oncology-related service provision will be fully compliant with the FAIR principles and complement and synergize with other relevant EU initiatives (e.g., EOSC, UNCAN.eu).
● To sustain the network and unified resources of the oncology-related service provision beyond the duration of the project;

IP IIS Aragón

Pedro Baptista

Organismo Financiador

Presupuesto total del Proyecto: 14.999.939 €
Presupuesto IIS Aragón: 20.000 €


Biobanks And Biomolecular Resources Research Infrastructure Consortium (Bbmri-eric), (Austria)


- Euro-bioimaging Eric (Finlandia)
- European Molecular Biology Laboratory (Alemania)
- Wageningen University (Holanda)
- Università Degli Studi di Torino (Italia)
- European Infrastructure of open screening Platforms for Chemical Biology European Research Infrastructure Consortium (Eu-openscreen Eric), (Alemania)
- Arttic Innovation Gmbh (Reino Unido)
- European Organisation for Research and Treatment of Cancer Aisbl (Bélgica)
- Centre International de Recherche sur le Cancer (Francia)
- Infrafrontier Gmbh (Alemania)
- European Marine Biological Resource Centre European Research Infrastructure Consortium (Francia)
- Ecrin European Clinical Research Infrastructure Network (Francia)
- European Cancer Patient Coalition (Bélgica)
- Fundacio Privada Institut d’Investigacio Oncologica de Vall-Hebron (Vhio), (España)
- Eatris Eric (Holanda)
- Universidade do Minho (Portugal)
- The University of Manchester (Reino Unido)
- Ttopstart Bv (Holanda)


01/04/2022 – 31/03/2025 (36 meses)

Página web